Found: 46
Select item for more details and to access through your institution.
Poor Applicability of Currently Available Prognostic Scoring Systems for Prediction of Outcome in KIT D816V-Negative Advanced Systemic Mastocytosis.
- Published in:
- Cancers, 2024, v. 16, n. 3, p. 593, doi. 10.3390/cancers16030593
- By:
- Publication type:
- Article
Step-in dosing of bosutinib in pts with chronic phase chronic myeloid leukemia (CML) after second-generation tyrosine kinase inhibitor (TKI) therapy: results of the Bosutinib Dose Optimization (BODO) Study.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 10, p. 2741, doi. 10.1007/s00277-023-05394-0
- By:
- Publication type:
- Article
Response and resistance to cladribine in patients with advanced systemic mastocytosis: a registry-based analysis.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 8, p. 2077, doi. 10.1007/s00277-023-05180-y
- By:
- Publication type:
- Article
Reverse Transcription Can Critically Impact the Diagnostic Outcome of BCR::ABL1 Quantitative Real-Time RT-PCR.
- Published in:
- Cancers, 2023, v. 15, n. 15, p. 3914, doi. 10.3390/cancers15153914
- By:
- Publication type:
- Article
Gene Expression Pattern of ESPL1 , PTTG1 and PTTG1IP Can Potentially Predict Response to TKI First-Line Treatment of Patients with Newly Diagnosed CML.
- Published in:
- Cancers, 2023, v. 15, n. 9, p. 2652, doi. 10.3390/cancers15092652
- By:
- Publication type:
- Article
A new aberrantly spliced BCR‐ABL1 transcript variant (e13a1) identified in routine monitoring using different quantitative reverse transcription polymerase chain reaction techniques in a patient with chronic myeloid leukemia.
- Published in:
- EJHaem, 2022, v. 3, n. 4, p. 1339, doi. 10.1002/jha2.553
- By:
- Publication type:
- Article
Atypical presentation of patients with chronic myeloid leukemia in chronic phase—Case report.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.960914
- By:
- Publication type:
- Article
Functional imaging with dual-energy computed tomography for supplementary non-invasive assessment of mast cell burden in systemic mastocytosis.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-18537-6
- By:
- Publication type:
- Article
Evidence for Recombinant GRP78, CALR, PDIA3 and GPI as Mediators of Genetic Instability in Human CD34+ Cells.
- Published in:
- Cancers, 2022, v. 14, n. 12, p. 2883, doi. 10.3390/cancers14122883
- By:
- Publication type:
- Article
Clinical and histopathological features of myeloid neoplasms with concurrent Janus kinase 2 (JAK2) V617F and KIT proto‐oncogene, receptor tyrosine kinase (KIT) D816V mutations.
- Published in:
- British Journal of Haematology, 2021, v. 194, n. 2, p. 344, doi. 10.1111/bjh.17567
- By:
- Publication type:
- Article
Proteins Marking the Sequence of Genotoxic Signaling from Irradiated Mesenchymal Stromal Cells to CD34+ Cells.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 11, p. 5844, doi. 10.3390/ijms22115844
- By:
- Publication type:
- Article
Genotoxic Bystander Signals from Irradiated Human Mesenchymal Stromal Cells Mainly Localize in the 10–100 kDa Fraction of Conditioned Medium.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 4, p. 827, doi. 10.3390/cells10040827
- By:
- Publication type:
- Article
First report on establishment and characterization of a carcinosarcoma tumour cell line model of the bladder.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-85400-5
- By:
- Publication type:
- Article
Adverse Prognostic Impact of the KIT D816V Transcriptional Activity in Advanced Systemic Mastocytosis.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 5, p. 2562, doi. 10.3390/ijms22052562
- By:
- Publication type:
- Article
Response to tyrosine kinase inhibitors in myeloid neoplasms associated with PCM1‐JAK2, BCR‐JAK2 and ETV6‐ABL1 fusion genes.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 7, p. 824, doi. 10.1002/ajh.25825
- By:
- Publication type:
- Article
Separase activity distribution can be a marker of major molecular response and proliferation of CD34<sup>+</sup> cells in TKI-treated chronic myeloid leukemia patients.
- Published in:
- 2020
- By:
- Publication type:
- journal article
An increased bone mineral density is an adverse prognostic factor in patients with systemic mastocytosis.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2020, v. 146, n. 4, p. 945, doi. 10.1007/s00432-019-03119-3
- By:
- Publication type:
- Article
DNA Damage and DNA Damage Response in Chronic Myeloid Leukemia.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 4, p. 1177, doi. 10.3390/ijms21041177
- By:
- Publication type:
- Article
Antileukemic Efficacy in Vitro of Talazoparib and APE1 Inhibitor III Combined with Decitabine in Myeloid Malignancies.
- Published in:
- Cancers, 2019, v. 11, n. 10, p. 1493, doi. 10.3390/cancers11101493
- By:
- Publication type:
- Article
Diagnostic performance of the molecular BCR-ABL1 monitoring system may impact on inclusion of CML patients in stopping trials.
- Published in:
- PLoS ONE, 2019, v. 14, n. 3, p. 1, doi. 10.1371/journal.pone.0214305
- By:
- Publication type:
- Article
Incidence and prognostic impact of cytogenetic aberrations in patients with systemic mastocytosis.
- Published in:
- Genes, Chromosomes & Cancer, 2018, v. 57, n. 5, p. 252, doi. 10.1002/gcc.22526
- By:
- Publication type:
- Article
The benefit of quality control charts (QCC) for routine quantitative BCR-ABL1 monitoring in chronic myeloid leukemia.
- Published in:
- PLoS ONE, 2018, v. 13, n. 4, p. 1, doi. 10.1371/journal.pone.0196326
- By:
- Publication type:
- Article
Effect of ABCG2, OCT1, and ABCB1 (MDR1) Gene Expression on Treatment-Free Remission in a EURO-SKI Subtrial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Increased separase activity and occurrence of centrosome aberrations concur with transformation of MDS.
- Published in:
- PLoS ONE, 2018, v. 13, n. 1, p. 1, doi. 10.1371/journal.pone.0191734
- By:
- Publication type:
- Article
Impact of centralized evaluation of bone marrow histology in systemic mastocytosis.
- Published in:
- European Journal of Clinical Investigation, 2016, v. 46, n. 5, p. 392, doi. 10.1111/eci.12607
- By:
- Publication type:
- Article
c-MYB is a transcriptional regulator of ESPL1/Separase in BCR-ABL-positive chronic myeloid leukemia.
- Published in:
- Biomarker Research, 2016, v. 4, p. 1, doi. 10.1186/s40364-016-0059-2
- By:
- Publication type:
- Article
Diagnostic challenges in the work up of hypereosinophilia: pitfalls in bone marrow core biopsy interpretation.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Impact of unbalanced minor route versus major route karyotypes at diagnosis on prognosis of CML.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Fusion of PDGFRB to MPRIP, CPSF6, and GOLGB1 in three patients with eosinophilia-associated myeloproliferative neoplasms.
- Published in:
- Genes, Chromosomes & Cancer, 2015, v. 54, n. 12, p. 762, doi. 10.1002/gcc.22287
- By:
- Publication type:
- Article
KIT D 816 V and JAK 2 V 617 F mutations are seen recurrently in hypereosinophilia of unknown significance.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 9, p. 774, doi. 10.1002/ajh.24075
- By:
- Publication type:
- Article
Measurement of Separase Proteolytic Activity in Single Living Cells by a Fluorogenic Flow Cytometry Assay.
- Published in:
- PLoS ONE, 2015, v. 10, n. 8, p. 1, doi. 10.1371/journal.pone.0133769
- By:
- Publication type:
- Article
Clonal Evolution and Blast Crisis Correlate with Enhanced Proteolytic Activity of Separase in BCR-ABL b3a2 Fusion Type CML under Imatinib Therapy.
- Published in:
- PLoS ONE, 2015, v. 10, n. 6, p. 1, doi. 10.1371/journal.pone.0129648
- By:
- Publication type:
- Article
Limited duration of complete remission on ruxolitinib in myeloid neoplasms with PCM1-JAK2 and BCR-JAK2 fusion genes.
- Published in:
- Annals of Hematology, 2015, v. 94, n. 2, p. 233, doi. 10.1007/s00277-014-2221-y
- By:
- Publication type:
- Article
Equivalence of BCR-ABL transcript levels with complete cytogenetic remission in patients with chronic myeloid leukemia in chronic phase.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2014, v. 140, n. 11, p. 1965, doi. 10.1007/s00432-014-1746-8
- By:
- Publication type:
- Article
Identification and functional characterization of imatinib-sensitive DTD1-PDGFRB and CCDC88C-PDGFRB fusion genes in eosinophilia-associated myeloid/lymphoid neoplasms.
- Published in:
- Genes, Chromosomes & Cancer, 2014, v. 53, n. 5, p. 411, doi. 10.1002/gcc.22153
- By:
- Publication type:
- Article
Younger patients with chronic myeloid leukemia do well in spite of poor prognostic indicators: results from the randomized CML study IV.
- Published in:
- Annals of Hematology, 2014, v. 93, n. 1, p. 71, doi. 10.1007/s00277-013-1937-4
- By:
- Publication type:
- Article
The KIT D816V expressed allele burden for diagnosis and disease monitoring of systemic mastocytosis.
- Published in:
- Annals of Hematology, 2014, v. 93, n. 1, p. 81, doi. 10.1007/s00277-013-1964-1
- By:
- Publication type:
- Article
Centrosome aberrations in bone marrow cells from patients with myelodysplastic syndromes correlate with chromosomal instability.
- Published in:
- Annals of Hematology, 2013, v. 92, n. 10, p. 1325, doi. 10.1007/s00277-013-1772-7
- By:
- Publication type:
- Article
Effects of imatinib mesylate in patients with polycythemia vera: results of a phase II study.
- Published in:
- Annals of Hematology, 2013, v. 92, n. 7, p. 907, doi. 10.1007/s00277-013-1725-1
- By:
- Publication type:
- Article
HERV-E-Mediated Modulation of PLA2G4A Transcription in Urothelial Carcinoma.
- Published in:
- PLoS ONE, 2012, v. 7, n. 11, p. 1, doi. 10.1371/journal.pone.0049341
- By:
- Publication type:
- Article
SNP array analysis of acute promyelocytic leukemia may be of prognostic relevance and identifies a potential high risk group with recurrent deletions on chromosomal subband 1q31.3.
- Published in:
- Genes, Chromosomes & Cancer, 2012, v. 51, n. 8, p. 756, doi. 10.1002/gcc.21961
- By:
- Publication type:
- Article
The Proteolytic Activity of Separase in BCR-ABL-Positive Cells Is Increased by Imatinib.
- Published in:
- PLoS ONE, 2012, v. 7, n. 8, p. 1, doi. 10.1371/journal.pone.0042863
- By:
- Publication type:
- Article
Detection of centrosome aberrations in disease-unrelated cells from patients with tumor treated with tyrosine kinase inhibitors.
- Published in:
- European Journal of Haematology, 2010, v. 85, n. 2, p. 139, doi. 10.1111/j.1600-0609.2010.01459.x
- By:
- Publication type:
- Article
Safety and efficacy of imatinib in chronic eosinophilic leukaemia and hypereosinophilic syndrome – a phase-II study.
- Published in:
- British Journal of Haematology, 2008, v. 143, n. 5, p. 707, doi. 10.1111/j.1365-2141.2008.07294.x
- By:
- Publication type:
- Article
Centrosome aberrations after nilotinib and imatinib treatment in vitro are associated with mitotic spindle defects and genetic instability.
- Published in:
- British Journal of Haematology, 2007, v. 138, n. 3, p. 369, doi. 10.1111/j.1365-2141.2007.06678.x
- By:
- Publication type:
- Article
Aneuploidy, the Primary Cause of the Multilateral Genomic Instability of Neoplastic and Preneoplastic Cells.
- Published in:
- IUBMB Life, 2004, v. 56, n. 2, p. 65, doi. 10.1080/15216540410001667902
- By:
- Publication type:
- Article